{"id":23257,"date":"2020-11-28T11:23:55","date_gmt":"2020-11-28T11:23:55","guid":{"rendered":"https:\/\/dailyhomeland.com\/?p=23257"},"modified":"2020-11-28T11:23:55","modified_gmt":"2020-11-28T11:23:55","slug":"us-operation-warp-speed-backed-vaccines-for-whole-world-2","status":"publish","type":"post","link":"https:\/\/dailyhomeland.com\/?p=23257","title":{"rendered":"US Operation Warp Speed backed vaccines for whole world"},"content":{"rendered":"<p>WASHINGTON, Nov 28, 2020 (BSS\/AFP) \u2013 President Donald Trump\u2019s announcement<br \/>\nin May of plans to develop a Covid-19 vaccine by year\u2019s end is near<br \/>\nrealization \u2014 despite a setback among one of the six candidates that the US<br \/>\nsupported.<\/p>\n<p>The president described the effort as \u201ca massive scientific, industrial and<br \/>\nlogistical endeavor unlike anything our country has seen since the Manhattan<br \/>\nProject,\u201d alluding to the US program during World War II to develop a nuclear<br \/>\nbomb.<\/p>\n<p>At the time Trump was accused of caring only about the US as the pandemic<br \/>\nraged worldwide in what some derided as \u201cvaccine nationalism.\u201d<\/p>\n<p>Trump called the vaccine project Operation Warp Speed, putting at its head<br \/>\na US army general and a former executive of pharmaceutical giant GSK.<\/p>\n<p>It brought together the scientific expertise of the Department of Health<br \/>\nand Human Services and military logistics experts.<\/p>\n<p>Six months later, what Trump has termed \u201ca miracle\u201d is at hand: a vaccine<br \/>\ndeveloped by Pfizer and BioNTech is being examined by the Food and Drug<br \/>\nAdministration for approval, some time shortly after December 10.<\/p>\n<p>And another vaccine developed by Moderna, a small US company, could follow<br \/>\nsuit quickly.<\/p>\n<p>In January the US multinational Johnson &amp; Johnson could present its own<br \/>\nclinical trial results to US regulators \u2014 boosting the US goal of having<br \/>\nvaccines available for all Americans by April.<\/p>\n<p>The operation relied on six projects, two each for three kinds of vaccine<br \/>\ntechnology so as to spread out the risk of one or more failing.<\/p>\n<p>Pfizer and Moderna worked on a new technology involving a molecule called<br \/>\nmessenger RNA.<\/p>\n<p>Meanwhile Johnson &amp; Johnson and AstraZeneca, working with the University of<br \/>\nOxford, focused on \u201cviral vectors.\u201d<\/p>\n<p>And Novavax and Sanofi\/GSK centered on a protein-based product to defeat<br \/>\nthe coronavirus.<\/p>\n<p>At first, the vaccine developed by AstraZeneca and Oxford was out in front,<br \/>\nwith its CEO announcing in June that the team would know if it was effective<br \/>\nby September.<\/p>\n<p>It suffered a first snag in early September when a participant in its<br \/>\nclinical trials fell ill. It took six weeks for the trials to resume in the<br \/>\nUS.<\/p>\n<p>Then questions emerged over good efficacy results announced by the<br \/>\ndevelopers, due to a dosage error. The team announced Thursday it needed to<br \/>\ndo another study.<\/p>\n<p>\u2013 \u2018An accelerating effect\u2019 \u2013<\/p>\n<p>The US can probably afford to go without the AstraZeneca candidate as it<br \/>\nawaits new data, as millions of Americans will be vaccinated with Pfizer or<br \/>\nModerna shots by December 31 if the FDA gives the green light.<\/p>\n<p>The rest of the world is also banking on the six Warp Speed vaccines, among<br \/>\ndozens of other candidates.<\/p>\n<p>The European Union has ordered doses from six manufacturers, five of which<br \/>\nare backed by the operation.<\/p>\n<p>\u201cThe force of investment has had an extremely important accelerating<br \/>\neffect,\u201d Loic Chabanier of the consulting firm EY told AFP.<\/p>\n<p>US government money allowed for the financing of clinical trials and the<br \/>\nretooling or construction of facilities to churn out vaccines.<\/p>\n<p>\u201cThe Americans financed clinical trials for the entire planet,\u201d Moderna CEO<br \/>\nStephane Bancel told AFP.<\/p>\n<p>The US ordered 100 million doses from the company, with bill payable even<br \/>\nif the vaccine had turned out to be a dud.<\/p>\n<p>\u201cI am not Pfizer or AstraZeneca,\u201d Bancel said. \u201cI need a lot of cash and do<br \/>\nnot have it.\u201d<\/p>\n<p>But experts generally avoid giving any credit to Trump, whose handling of<br \/>\nthe pandemic is criticized as disastrous, relying solely on vaccines to end<br \/>\nthe pandemic and failing to push public health measures that could have saved<br \/>\ntens of thousands of lives.<\/p>\n<p>\u201cAmerica is very good at this sort of thing. Not good at prevention. Not<br \/>\ngood at public health management, in this case a pandemic, but good at life<br \/>\nscience,\u201d said Eric Topol, head of the Scripps Research Translational<br \/>\nInstitute, who is highly critical of Trump.<\/p>\n<p>\u201cThis is a strength of the US. It isn\u2019t Trump. Okay, they throw money at<br \/>\nit, billions of dollars contingent on the vaccines working. But it was the<br \/>\ncompanies that drove this,\u201d Topol said.<\/p>\n<p>He also praised the National Institutes of Health, the government agency<br \/>\nthat co-developed the Moderna vaccine and managed its clinical trials and<br \/>\nthose of others.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>WASHINGTON, Nov 28, 2020 (BSS\/AFP) \u2013 President Donald Trump\u2019s announcement in May of plans to develop a Covid-19 vaccine by year\u2019s end is near realization \u2014 despite a setback among one of the six candidates that the US supported. The president described the effort as \u201ca massive scientific, industrial and logistical endeavor unlike anything our [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":23259,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"spay_email":"","jetpack_publicize_message":"","jetpack_is_tweetstorm":false},"categories":[48,40],"tags":[],"jetpack_featured_media_url":"https:\/\/i.imgur.com\/V6GcX6x.jpg","jetpack_publicize_connections":[],"_links":{"self":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts\/23257"}],"collection":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=23257"}],"version-history":[{"count":1,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts\/23257\/revisions"}],"predecessor-version":[{"id":23258,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts\/23257\/revisions\/23258"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/media\/23259"}],"wp:attachment":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=23257"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=23257"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=23257"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}